Home
IMUX
IMUX News

Latest Immunic Inc. (IMUX) News on February 22, 2025

Immunic, Inc.'s (NASDAQ:IMUX) largest shareholders are retail investors who were rewarded as market cap surged US$24m last week

Simply Wall St.

10 hours ago

Immunic, Inc.'s (NASDAQ:IMUX) largest shareholders are retail investors who were rewarded as market cap surged US$24m last week

Immunic's Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing

PR Newswire

2 days ago

Immunic's Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing

Immunic to Participate in Investor and Scientific Conferences in February

PR Newswire

18 days ago

Immunic to Participate in Investor and Scientific Conferences in February

Immunic Highlights 2024 Accomplishments and Upcoming Milestones

PR Newswire

a month ago

Immunic Highlights 2024 Accomplishments and Upcoming Milestones

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

ACCESSWIRE

3 months ago

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

Immunic, Inc. to Participate in Investor Conference in December

PR Newswire

3 months ago

Immunic, Inc. to Participate in Investor Conference in December

Insider Buys Additional US$100k In Immunic Stock

Simply Wall St.

3 months ago

Insider Buys Additional US$100k In Immunic Stock

Immunic announces publication of IMU-856 data

TipRanks

3 months ago

Immunic announces publication of IMU-856 data

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology

PR Newswire

3 months ago

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology

Immunic Inc (IMUX) Q3 2024 Earnings Call Highlights: Strategic Progress Amid Financial Challenges

GuruFocus.com

3 months ago

Immunic Inc (IMUX) Q3 2024 Earnings Call Highlights: Strategic Progress Amid Financial Challenges

Associated Press Finance

3 months ago

Immunic: Q3 Earnings Snapshot

Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update

PR Newswire

3 months ago

Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

PR Newswire

4 months ago

Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

Immunic to Participate in Industry, Scientific and Investor Conferences in November

PR Newswire

4 months ago

Immunic to Participate in Industry, Scientific and Investor Conferences in November

MT Newswires

4 months ago

Immunic Shares Advance on Positive Outcome From Interim Analysis of Potential MS Treatment

MT Newswires

4 months ago

Top Premarket Gainers

Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis

PR Newswire

4 months ago

Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis

We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully

Simply Wall St.

4 months ago

We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully

MT Newswires

4 months ago

Top Premarket Gainers

Immunic Inc (IMUX) Q2 2024 Earnings Call Highlights: Promising Clinical Data and Financial ...

GuruFocus.com

4 months ago

Immunic Inc (IMUX) Q2 2024 Earnings Call Highlights: Promising Clinical Data and Financial ...

MT Newswires

5 months ago

Immunic Says Initial Phase 2 Data Back Vidofludimus Calcium's Potential in Multiple Sclerosis

Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis

PR Newswire

5 months ago

Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis

Owning 39% shares,hedge funds owners seem interested in Immunic, Inc. (NASDAQ:IMUX),

Simply Wall St.

5 months ago

Owning 39% shares,hedge funds owners seem interested in Immunic, Inc. (NASDAQ:IMUX),

Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome

PR Newswire

6 months ago

Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September

PR Newswire

6 months ago

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September

MT Newswires

6 months ago

B. Riley Securities Initiates Immunic at Buy With $6 Price Target

Associated Press Finance

6 months ago

Immunic: Q2 Earnings Snapshot

Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update

PR Newswire

6 months ago

Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update

PR Newswire

7 months ago

Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec

PR Newswire

7 months ago

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec

MT Newswires

7 months ago

Immunic Names Jason Tardio as COO, Werner Gladdines as Chief Development Officer

Immunic Appoints Jason Tardio as Chief Operating Officer and President

PR Newswire

7 months ago

Immunic Appoints Jason Tardio as Chief Operating Officer and President

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

8 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

8 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

8 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

8 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

8 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

8 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

8 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PR Newswire

8 months ago

Enduring role of 'treasuring the past' hailed

When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?

Simply Wall St.

9 months ago

When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?

Immunic to Participate in Industry and Scientific Conferences in June

PR Newswire

9 months ago

Immunic to Participate in Industry and Scientific Conferences in June

Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript

We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully

Simply Wall St.

9 months ago

We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully

Associated Press Finance

9 months ago

Immunic: Q1 Earnings Snapshot

Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update

PR Newswire

9 months ago

Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update

Immunic to Participate in Investor and Scientific Conferences in May

PR Newswire

10 months ago

Immunic to Participate in Investor and Scientific Conferences in May

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

News Direct

10 months ago

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

PR Newswire

10 months ago

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation

PR Newswire

10 months ago

Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation

Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role

News Direct

10 months ago

Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role

With 44% ownership, Immunic, Inc. (NASDAQ:IMUX) has piqued the interest of hedge funds investors

Simply Wall St.

a year ago

With 44% ownership, Immunic, Inc. (NASDAQ:IMUX) has piqued the interest of hedge funds investors

Immunic to Host MS R&D Day and Participate in Investor Conferences in April

PR Newswire

a year ago

Immunic to Host MS R&D Day and Participate in Investor Conferences in April

Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month

News Direct

a year ago

Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month

Immunic secures key patent, boosting MS drug exclusivity and global IP strategy

News Direct

a year ago

Immunic secures key patent, boosting MS drug exclusivity and global IP strategy

Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States

PR Newswire

a year ago

Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States

Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024

News Direct

a year ago

Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024

Immunic to Participate in Investor and Scientific Conferences in March

PR Newswire

a year ago

Immunic to Participate in Investor and Scientific Conferences in March

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

PR Newswire

a year ago

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

GuruFocus.com

a year ago

Immunic Inc (IMUX) Reports Year-End 2023 Financial Results

Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript

Immunic reports successful 2023 and prepares for key 2025 milestones

News Direct

a year ago

Immunic reports successful 2023 and prepares for key 2025 milestones

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

PR Newswire

a year ago

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update

PR Newswire

a year ago

Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update

Immunic to Participate in Investor and Scientific Conferences in February

PR Newswire

a year ago

Immunic to Participate in Investor and Scientific Conferences in February

Business Wire

a year ago

Tillys Announces Leadership Transition

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors

Barrons.com

a year ago

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

GlobeNewswire

a year ago

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

WeightWatchers Unveils “Beyond Hunger: Understanding Food Noise” Report Offering Insights Into the Experience of Ongoing, Intrusive Thoughts About Food

GlobeNewswire

a year ago

WeightWatchers Unveils “Beyond Hunger: Understanding Food Noise” Report Offering Insights Into the Experience of Ongoing, Intrusive Thoughts About Food

GlobeNewswire

a year ago

K. Hovnanian®️ Introduces Salerno Reserve, a New LOOKS Community in Stuart, FL

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

GlobeNewswire

a year ago

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

Business Wire

a year ago

Solo Brands Announces Leadership Change to Support Its Next Chapter of Growth

Is Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) 3.2% ROE Worse Than Average?

Simply Wall St.

a year ago

Is Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) 3.2% ROE Worse Than Average?

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

PR Newswire

a year ago

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Immunic, Inc. Announces Private Placement of up to $240 Million

PR Newswire

a year ago

Immunic, Inc. Announces Private Placement of up to $240 Million

Business Wire

a year ago

GAN Announces Launch of GAN Sports with Red Rock Resorts, Inc. under the STN Sports Brand

Business Wire

a year ago

GAN Announces Changes to its Board of Directors

Zacks.com featured highlights Park Hotels & Resorts, Centene, Solo Brands and AZZ

Zacks

a year ago

Zacks.com featured highlights Park Hotels & Resorts, Centene, Solo Brands and AZZ

Director Vincent Pagano Sells Shares of Hovnanian Enterprises Inc

GuruFocus.com

a year ago

Director Vincent Pagano Sells Shares of Hovnanian Enterprises Inc

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

TPI and Nordex Extend and Expand Contract in Türkiye

GlobeNewswire

a year ago

TPI and Nordex Extend and Expand Contract in Türkiye

Aeva to Showcase World’s First Automotive-Grade FMCW 4D LiDAR for Advanced Driver Assist and Autonomy in Production Vehicles at CES 2024

Business Wire

a year ago

Aeva to Showcase World’s First Automotive-Grade FMCW 4D LiDAR for Advanced Driver Assist and Autonomy in Production Vehicles at CES 2024

Ondas Holdings Inc. (NASDAQ:ONDS) Shares Could Be 32% Above Their Intrinsic Value Estimate

Simply Wall St.

a year ago

Ondas Holdings Inc. (NASDAQ:ONDS) Shares Could Be 32% Above Their Intrinsic Value Estimate

Asure Releases Third Quarter 2023 Results Showing 34% y/y Revenue Growth, Issues Preliminary FY 2024 Guidance

ACCESSWIRE

a year ago

Asure Releases Third Quarter 2023 Results Showing 34% y/y Revenue Growth, Issues Preliminary FY 2024 Guidance

Penns Woods Bancorp (NASDAQ:PWOD) Is Due To Pay A Dividend Of $0.32

Simply Wall St.

a year ago

Penns Woods Bancorp (NASDAQ:PWOD) Is Due To Pay A Dividend Of $0.32

Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago

Simply Wall St.

a year ago

Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago

TRX Gold Reports Year-End 2023 Results

GlobeNewswire

a year ago

TRX Gold Reports Year-End 2023 Results

BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC

GlobeNewswire

a year ago

BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

GlobeNewswire

a year ago

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

Great week for Intevac, Inc. (NASDAQ:IVAC) institutional investors after losing 31% over the previous year

Simply Wall St.

a year ago

Great week for Intevac, Inc. (NASDAQ:IVAC) institutional investors after losing 31% over the previous year

Natuzzi S.p.A.: Shareholder Letter and Financial Results 2023 Third Quarter Results

Business Wire

a year ago

Natuzzi S.p.A.: Shareholder Letter and Financial Results 2023 Third Quarter Results

Natuzzi's (NYSE:NTZ) Returns On Capital Are Heading Higher

Simply Wall St.

a year ago

Natuzzi's (NYSE:NTZ) Returns On Capital Are Heading Higher

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dosing Regimens in Multiple Sclerosis

PR Newswire

a year ago

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dosing Regimens in Multiple Sclerosis

GlobeNewswire

a year ago

DayDayCook Announces Pricing of Initial Public Offering

7 Small-Cap Stocks Set to Soar as Interest Rates Stabilize

InvestorPlace

a year ago

7 Small-Cap Stocks Set to Soar as Interest Rates Stabilize

Immunic focusing on business development during Q4

News Direct

a year ago

Immunic focusing on business development during Q4

Associated Press Finance

a year ago

Immunic: Q3 Earnings Snapshot

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update

PR Newswire

a year ago

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Associated Press Finance

a year ago

Cadiz: Q3 Earnings Snapshot

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Simply Wall St.

a year ago

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Share on Social Networks: